RIPK1 and neurodegenerative disease: Furthermore, RIPK1 kinase activity emerged as driver of ischemic injury18–20 as well as neurodegenerative diseases such as multiple sclerosis (MS)21, ALS (amyotrophic lateral sclerosis)22 and Alzheimer’s disease23.